F. Blasi (Milan, Italy), P. J. M. Openshaw (London, United Kingdom)
Severe acute respiratory syndrome (SARS): correlation of clinical outcome and radiological features D. S. Hui, K. T. Wong, G. E. Antonio, A. T. Ahuja, M. C. Chan, J. J. Sung (Shatin, Hong Kong)
| |
Pulmonary function and functional capacity in survivors of severe acute respiratory syndrome D. S. Hui, K. T. Wong, A. E. Gregory, F. W. Ko, M. C. Chan, J. P. Fok, A. T. Ahuja, J. J. Sung (Shatin, Hong Kong)
| |
Pulmonary function in patients recovering from severe acute respiratory syndrome (SARS) D. W. L. Tong, M. C. Chui, W. C. Yu (Hong Kong, China)
| |
Duration of RT-PCR positivity after discharge in severe acute respiratory syndrome (SARS) W. S. Leung, C. M. Chu, V. L. Chan, A. W. Lin, J. Y. Lam (Kowloon, Hong Kong)
| |
Characterization of cytokine and chemokine profiles in the development of the severe acute respiratory syndrome(SARS) J. Xu, Y. Jiang, S. Zhong, C. Zhou, J. Liu, T. Cheng (Guangzhou, China)
| |
An acute bronchitis questionnaire (AECB-SS) discriminates between GOLD categories for COPD severity in patients screened for the MOSAIC study S. Spencer, P. W. Jones, I. Duprat-Lomon, P. P. Sagnier, R. Wilson (Uxbridge, London, United Kingdom; Puteaux, France)
| |
High rate of multiple viral infections of lower respiratory tract M. M. Gencay, D. Jaccard-Stolz, M. Christ-Crain, B. Müller, M. Tamm (Basel, Switzerland)
| |
Value of measuring SGRQ at stable phase of COPD to predict the timing and deterioration associated with next exacerbation: the MOSAIC study P. W. Jones, S. Spencer, I. Duprat-Lomon, P. P. Sagnier, R. Wilson (London, Uxbridge, United Kingdom; Puteaux, France)
| |
Chlamydia pneumoniae persists in COPD lung tissue: predominant role of toll-like receptor 2 versus 4 in chlamydia pneumoniae-induced activation of pulmonary immune cells D. Droemann, J. Rupp, T. Goldmann, M. Maass, D. Branscheid, P. Zabel, K. Dalhoff (Borstel, Luebeck, Großhansdorf, Germany)
| |
Quantitative evaluation of chlamydia psittaci infection in three different forms of pulmonary emphysema O. Anhenn, T. Bexten, G. Stamatis, D. Theegarten (Bochum, Essen, Germany)
| |
Sputum color as a marker for bacterial infection in severe acute exacerbations of COPD J. M. A. Daniels, C. S. De Graaff, F. Vlaspolder, W. G. Boersma (Alkmaar, The Netherlands)
| |
Immunological techniques in the detection of streptococcus pneumoniae in pleural effusion F. Andreo, J. Domínguez, J. Ruiz, S. Blanco, L. Lores, C. Prat, X. Casas, V. Ausina (Barcelona, Spain)
| |
The discriminatory value of procalcitonin (PCT) and C-reactive protein (CRP) levels in HIV-seropositive patients presenting with community acquired pneumonia (CAP) due to pulmonary tuberculosis (PTB) compared with patients with pneumococcal pneumonia G. K. Schleicher, C. Feldman, A. Brink, J. S. Galpin, S. Martin, R. Maraj (Johannesburg, South Africa)
| |
Non-infectious pulmonary complications in immunocompromised (IC) patients. Associated pulmonary and systemic inflammatory response O. Sibila, A. Rano, C. Agusti, X. Filella, M. Rovira, A. Torres (Barcelona, Spain)
| |
Effect of corticoids on the clinical course and outcome of severe community-acquired pneumonia S. Fernandez, J. Dorca, S. Padrones, A. Fernandez-Aguera, F. Gudiol, F. Manresa (Barcelona, Spain)
| |
Nosocomial pneumonia. Research of predisposing factors in a case-control study B. Miranda, L. Molinos, M. Alonso, L. Carazo, F. López, S. Cadenas, J. Martínez, C. Escudero, T. G. Budiño (Oviedo, Spain)
| |
Adherence to guidelines and clinical stability in community-acquired pneumonia R. Menendez, A. Torres, Neumofail Group (Valencia, Barcelona, Group, Spain)
| |
Frequency of the occurrence of atypical pathogens in hospitalized patients with CAP: a multi-country study F. Blasi, M. Tamm, P. A. Wilcox, S. Fisher, P. Hogan (Milan, Italy; Basel, Switzerland; Cape Town, South Africa; New York, United States Of America)
| |
Etiology of community acquired pneumonia in the Valencian Community (Spain). A multicentric prospective one-year survey F. Sanz, J. Blanquer, M. Briones, C. Ferrando, R. Blanquer (Comunidad Valenciana, Spain)
| |
Clinical characteristics and antibiotic prescribing in patients admitted with community acquired pneumonia to a university hospital in Pakistan S. F. Hussain, M. Irfan, A. Noor, K. Mapara, S. Memon (Karachi, Pakistan)
| |